Oppenheimer Asset Management’s iShares US Medical Devices ETF IHI Stock Holding History

Oppenheimer Asset Management’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,745	Closed	-$510K	–	1217
2021 Q4	$510K	Sell	7,745 -258	-3%	-$16.5K	0.01%	957
2021 Q3	$502K	Sell	8,003 -541	-6%	-$34.5K	0.01%	935
2021 Q2	$514K	Sell	8,544 -174	-2%	-$10.1K	0.01%	947
2021 Q1	$480K	Sell	8,718 -264	-3%	-$14.6K	0.01%	921
2020 Q4	$490K	Sell	8,982 -156	-2%	-$8.15K	0.01%	870
2020 Q3	$456K	Buy	+9,138	New	+$443K	0.01%	840
2020 Q1	–	Sell	-19,902	Closed	-$877K	–	1564
2019 Q4	$877K	Buy	19,902 +10,704	+116%	+$450K	0.02%	664
2019 Q3	$379K	Buy	9,198 +198	+2%	+$8.11K	0.01%	872
2019 Q2	$361K	Sell	9,000 -114	-1%	-$4.32K	0.01%	907
2019 Q1	$352K	Buy	+9,114	New	+$331K	0.01%	891

Other funds holding IHI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return

Oppenheimer Asset Management's IHI Position: Q1 2022 in Review

Oppenheimer Asset Management sold out of iShares US Medical Devices ETF (IHI) in Q1 2022, closing a stake of 7,745 shares — an estimated $510K sold.

Oppenheimer Asset Management first reported a position in IHI in Q1 2019 and held it in 10 quarters. The position peaked at $877K in Q4 2019. 631 funds tracked by Wall St. Rank hold IHI as of Q1 2022.

Oppenheimer Asset Management reported no remaining iShares US Medical Devices ETF position as of Q1 2022 after selling out during the quarter.
Oppenheimer Asset Management sold 7,745 iShares US Medical Devices ETF shares in Q1 2022, an estimated $510K.
Oppenheimer Asset Management first reported a position in iShares US Medical Devices ETF in Q1 2019 and held it in 10 quarters.
Oppenheimer Asset Management's iShares US Medical Devices ETF position peaked at $877K in Q4 2019.
631 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2022.

Based on Oppenheimer Asset Management's 13F filing for Q1 2022, filed 12 May 2022.